KPTI (STOCKS)
Karyopharm Therapeutics Inc.
$9.130000
+1.760000 (+23.88%)
Prev close: $7.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Richard A. Paulson, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $78.23M
- Employees
- 279
- P/E (TTM)
- -0.61
- P/B (TTM)
- -0.29
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $96.23M |
| Current Assets | $89.75M |
| Cash | $45.90M |
| Accounts Receivable | $31.88M |
| Inventory | $3.97M |
| Other Current Assets | $8.00M |
| Noncurrent Assets | $6.49M |
| Fixed Assets | $122.00K |
| Other Non-current Assets | $6.36M |
| Liabilities | $365.49M |
| Current Liabilities | $87.16M |
| Accounts Payable | $5.39M |
| Other Current Liabilities | $81.77M |
| Noncurrent Liabilities | $278.33M |
| Equity | -$269.26M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$269.26M |
| Liabilities And Equity | $96.23M |